Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Epivir (Lamivudine) Tablets & Oral Solution
Company:  GlaxoSmithKline
Application No.:  020564s012 & 020596s013
Approval Date: 3/06/2001


Date created: January 6, 2005

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.